Sources: Drug Shortages | FDA FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA Facts About the Current Good Manufacturing Practice (CGMP) | FDA FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products | FDA FDA and Novo Nordisk Warned of GLP-1 Telehealth Compounding Takedown
Gq/11 interacts with PLC, which may split a fat-like molecule, phosphatidylinositol 4,5-bisphosphate (PIP2), into two messaging molecules: IP3 (Inositol trisphosphate) and DAG (Diacylglycerol)
About 15% of people have side effects bad enough to make them stop taking the drug according to clinical data
We changed pharmacy vendor, now you cant get it unless you have had a history of diabetes. Senior Benefits Manager, large manufacturer Weve never offered it for weight loss, and it is still one of our top three prescriptions spends every year. HR Professional, large manufacturer We dont allow GLP-1s for weight loss In our type 2 diabetes population, 50% are utilizing the GLP-1s, so we are now excluding them for anything except type 2 diabetes [to manage costs]. Director of Benefits, large manufacturer The future of GLP-1 drug prices Employers are also recognizing that the price paid by employers for GLP-1 drugs are sometimes higher than online direct-to-consumer prices reflecting manufacturer discounts